About Eucare Pharmaceuticals
Eucare Pharmaceuticals is a Healthcare company based in Chennai (India) founded in 1996. Developer of collagen technologies and drug delivery systems. The company has 140 employees. Eucare Pharmaceuticals was last valued at $382.57 thousand in September 2010. Its Indian entity Eucare Pharmaceuticals P Ltd reported revenue of ₹38.35 Cr. Eucare Pharmaceuticals offers products and services including Kollagen®, BioFil®, NeuSkin™, GelSpon®, and PerioCol®-GTR. Its focus areas include Life Sciences, Wound Care, Medical Devices and Therapeutic Devices.
Company details
Eucare Pharmaceuticals was founded in 1996 in Chennai, India, where collagen technologies and drug delivery systems are developed within the medical devices sector. Collagen-based dressings in forms such as sheets and gels are produced for burns, trauma, and chronic wounds using patented methods. Additional devices including membranes, sponges, medicated options, silicone scar products, hydrocolloids, hydrogels, and hydrophilic foams are manufactured.
- Headquarters Chennai, India
- Employees 140
- SectorsHealthcare
- Website eucareindia.com
- Social LinkedIn
- Legal Name Eucare Pharmaceuticals P Ltd
- Date of Incorporation 18 Mar, 1996
- Jurisdiction Tamil Nadu, India
- Annual Revenue₹38.35 Cr
FY 2026 · +9% YoY
- Net Loss-₹3.86 Cr
FY 2026 · -10% margin
- EBITDA-₹22.2 Lakh
FY 2026 · -1% margin
- InvestorsBalaji Mariline
& 2 more
- Employee Count140
Associated legal entities of Eucare Pharmaceuticals
Eucare Pharmaceuticals is associated with 2 registered companies on The Company Check; the primary company is Eucare Pharmaceuticals P Ltd. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Eucare Pharmaceuticals P Ltd CIN U24231TN1996PTC034848 | Active | 18 Mar 1996 | ₹38.4 Cr | 140 | 4 | View details | |
| Eucare Life Sciences Private Limited CIN U36100TN2013PTC090013 | Strike Off | 13 Mar 2013 | Chennai, Tamil Nadu | 3 | View details |
Products & Services of Eucare Pharmaceuticals
Eucare Pharmaceuticals offers a comprehensive portfolio of products and services, including Kollagen®, BioFil®, NeuSkin™, GelSpon®, and PerioCol®-GTR.
Bovine-based collagen membrane for effective treatment of burns and skin substitutes.
Advanced dressing that promotes healing for various wound types.
Collagen product designed for managing burns and related skin issues.
Hemostatic agent used for controlling bleeding in surgical procedures.
Collagen membrane for guided tissue regeneration in dental applications.
Funding Insights of Eucare Pharmaceuticals
- Total Rounds 3
- Investors Count 3
All 3 funding rounds of Eucare Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2022 | Series A | – | – | ||
| Apr 2013 | Unspecified | – | – | ||
| Sep 2010 | Unspecified | $382,572 | Balaji Mariline | – |
Last known valuation $382,572 (Sep 2010). 3 investors in total: 3 institutional.
Investors in Eucare Pharmaceuticals
Eucare Pharmaceuticals has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Balaji Mariline, Healthcare Asia and Urgo Medical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Imports and distributes therapeutic products competitively in Asia. | 2016 | healthcareasiapac.com | Singapore, Singapore | |
Medical devices are manufactured by Urgo Medical in France. | urgomedical.com | Chenove, France | ||
Delivers comprehensive air and ocean freight forwarding solutions. | 1989 | balajimariline.com | Delhi, India |
Investor details for Eucare Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Eucare Pharmaceuticals P Ltd (Eucare Pharmaceuticals)
Eucare Pharmaceuticals P Ltd is the primary company behind Eucare Pharmaceuticals. The boards of the 2 registered companies of Eucare Pharmaceuticals currently have 7 directors; the longest-serving is Sankara Raman Santha Kamakshi, appointed in 2013. 13 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sankara Raman Santha Kamakshi DIN 00612201 | Director | 13 Mar 2013 | 13 yrs 8 mo | Eucare Life Sciences Private Limited |
| Sridharan DIN 01000974 | Director | 13 Mar 2013 | 13 yrs 8 mo | Eucare Life Sciences Private Limited |
| Harikishore Sridharan DIN 06486594 | Director | 13 Mar 2013 | 13 yrs 8 mo | Eucare Life Sciences Private Limited |
| Guirec Le Lous DIN 08620215 | Director | 25 Nov 2019 | 6 yrs 11 mo | Eucare Pharmaceuticals P Ltd |
| Gavin John Ashton DIN 08620253 | Director | 25 Nov 2019 | 6 yrs 11 mo | Eucare Pharmaceuticals P Ltd |
| Pratik Santosh Bhide DIN 09420708 | Managing Director | 09 Jun 2022 | 4 yrs 5 mo | Eucare Pharmaceuticals P Ltd |
| Javier Camps Hernan Perez DIN 10881268 | Director | 20 Jan 2025 | 1 yr 9 mo | Eucare Pharmaceuticals P Ltd |
Financials of Eucare Pharmaceuticals
Figures of Eucare Pharmaceuticals P Ltd, the primary company behind Eucare Pharmaceuticals, for FY 2026. Revenue was ₹38.35 Cr (+9% year on year). Net loss was -₹3.86 Cr (-10% margin). EBITDA was -₹22.2 Lakh (-1% margin). Revenue has grown at a compounded annual rate of +1163% over three years and +22% over five years.
- ₹38.35 CrRevenue · FY 2026 · +9% YoY
- -₹3.86 CrNet loss · -10% margin
- -₹22.2 LakhEBITDA · -1% margin
- ₹88.7 LakhPaid-up capital
- 140Employees (provident fund records)
- +1163%Revenue CAGR, 3 years
- +22%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Eucare Pharmaceuticals P Ltd are on its company page.
Detailed financial statements for Eucare Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Eucare Pharmaceuticals
3 dated milestones of Eucare Pharmaceuticals across 26 years, from founding to its latest funding, stage changes and deals.
- Founded Eucare Pharmaceuticals is founded.
- Funding First funding round.
- Funding Latest funding round, Series A,.
Web traffic of Eucare Pharmaceuticals
The website of Eucare Pharmaceuticals (eucareindia.com) receives about 1.3K visits a month.
- Monthly visits1.3K
▲ 519.9% vs previous month
Websites whose visitors overlap most with Eucare Pharmaceuticals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| fourrts.com | 100% | 13.9K | #2,054,904 | View details | |
| orchidpharma.com | 100% | 2.8K | #4,402,094 | View details | |
pharmatips.doyouknow.in | pharmatips.doyouknow.in | 100% | – | ||
harchhyperbarics.com | harchhyperbarics.com | 63% | – | ||
| vopecpharma.com | 62% | 7.2K | #11,305,869 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 13 similar websites and full traffic analytics for Eucare Pharmaceuticals
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Eucare Pharmaceuticals
Complete news archive for Eucare Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eucare Pharmaceuticals
Eucare Pharmaceuticals was founded in 1996 and raised its 1st funding round 14 years after it was founded.
Eucare Pharmaceuticals is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Eucare Pharmaceuticals has 140 employees.
The primary company behind Eucare Pharmaceuticals, Eucare Pharmaceuticals P Ltd, reported revenue of â‚ą38.35 Cr for FY 2026, up 9% year on year.
Eucare Pharmaceuticals was founded in 1996 in Chennai, India, where collagen technologies and drug delivery systems are developed within the medical devices sector. Collagen-based dressings in forms such as sheets and gels are produced for burns, trauma, and chronic wounds using patented methods. Additional devices including membranes, sponges, medicated options, silicone scar products, hydrocolloids, hydrogels, and hydrophilic foams are manufactured.
Eucare Pharmaceuticals offers Kollagen®, BioFil®, NeuSkin™, GelSpon®, and PerioCol®-GTR.
Eucare Pharmaceuticals has 3 investors. Key investors include Balaji Mariline, Healthcare Asia, and Urgo Medical.
The valuation of Eucare Pharmaceuticals is $382.57K as of Sep 2010.
Eucare Pharmaceuticals is associated with 2 legal entities: Eucare Pharmaceuticals P Ltd, Eucare Life Sciences Private Limited.
The legal entities of Eucare Pharmaceuticals currently have 7 directors, including Sankara Raman Santha Kamakshi, Sridharan, Harikishore Sridharan and others.